Issues in the design of new clinical trials for rheumatoid arthritis therapeutics
{{output}}
Rheumatoid arthritis (RA) is a chronic, heterogeneous disease, for which there has traditionally been few reliable prognostic indicators or simple clinical outcome measures with which to adequately assess disease status or clinical improvement. These challenge... ...